Navigation Links
Prasco® Selected as Eli Lilly and Company's Authorized Generics Partner
Date:10/20/2011

CINCINNATI, Oct. 20, 2011 /PRNewswire/ -- Prasco Laboratories, announced today it has signed a marketing and distribution agreement with Eli Lilly and Company (NYSE: LLY) to market the Authorized Generic version of ZYPREXA® (olanzapine) Tablets and ZYPREXA® ZYDIS (olanzapine) Orally Disintegrating Tablets, in the U.S.

Prasco will begin distribution of both products upon the first ANDA entrant into the market.  Prasco will market all six strengths of Olanzapine Tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg.  Olanzapine Orally Disintegrating Tablets will be available in 5 mg, 10 mg, 15 mg, and 20 mg strengths. The financial terms of the agreement were not disclosed.

"Prasco's passion to bring high quality, low cost prescription drugs to consumers continues to expand," said Prasco Chief Executive Officer E. Thomas Arington. "We are especially excited to welcome Eli Lilly and Company to our Prasco family of partners."

Prasco is established as the Authorized Generics company, having brought more Authorized Generics to market than any other company by offering generic products that are identical to the Brand product. "Prasco partnerships with brand companies offer alternatives for consumers and pharmacists that are specific and measurable. This is especially true with the Olanzapine launch through our new Lilly relationship," Arington concluded.  

Olanzapine Tablets are therapeutically equivalent and substitutable for the brand ZYPREXA.  Olanzapine Orally Disintegrating Tablets are therapeutically equivalent and substitutable for the brand ZYPREXA ZYDIS.  

For additional information about ZYPREXA and ZYPREXA ZYDIS, please see Full Prescribing Information including Box Warning at http://pi.lilly.com/us/zyprexa-pi.pdf and Medication Guide at http://pi.lilly.com/us/zyprexa-medguide.pdf.

About Prasco Laboratories - Prasco, the Authorized Generics company, is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics. Prasco Authorized Generics also simplify interactions between pharmacists and consumers because they are identical to branded drugs. Moreover, Prasco Authorized Generics offer brand pharmaceutical companies a strategic lifecycle management solution.

Prasco sells its product line through the major distribution channels, and operates from a cGMP compliant, VAWD certified 160,000 sq. ft. office and distribution center including DEA-approved capabilities for Schedule II-V controlled drug products and cold-chain distribution. For more information, visit www.prasco.com.

For additional information about ZYPREXA and/or ZYPREXA ZYDIS, please contact:  Stefanie Prodouz, Manager, Lilly Bio-Medicines Communications | 317.224.5331.


'/>"/>
SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prasco® Launches Authorized Generic with Shionogi Inc.
2. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
3. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
4. Christine Pierre Selected as "Professional Woman of the Year"
5. Dr. Paul Farmer Selected as 2011 Pro Bono Humanum Honoree by Prix Galien USA
6. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
7. BioSurplus Selected to Auction $10 Million in Lab Equipment
8. Linet Multicare® Hospital Bed Selected to Participate in National Program Highlighting Commitment to Healthcare Performance Improvement, Innovation
9. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
10. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
11. Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... quarter and full year 2016 financial results on Thursday, March ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 p.m. ... obtained as follows: Thursday, March 2 1:30 ...
(Date:2/22/2017)... 2017  Andre, DiMino, CEO of ADM Tronics Unlimited, ... innovative technologies and products, commented on ADMT,s third quarter ... 2017 in the Company,s quarterly report on Form 10Q ... Andre, DiMino stated "During the quarter ended December 31, ... a larger portion of our engineering efforts into the ...
(Date:2/22/2017)... Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer ... the semiconductor capital equipment, flat panel, medical, energy ... for the fourth quarter and fiscal year ended ... year of extraordinary growth for UCT. Total revenue ... with continued focus on operational excellence resulted in ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... ... The Waismann Method® is providing a faster, safer, and more ... to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... shame, stigma, and harmful labeling believed to prevent many of these victims ...
(Date:2/22/2017)... ... ... South Bend’s Lunkerville, the award-winning TV series that catches real people with real ... non-profit organization dedicated to helping military veterans relax, rehabilitate, and reintegrate through kayak fishing. ... Denmark, New Jersey, to fish with war veteran Justin Vail from the New Jersey ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... adults with chronic conditions reported skipping doses or not filling a prescription because ... or under-insured, rates of cost-related problems getting medications were 30-60%*. At ...
(Date:2/22/2017)... ... 22, 2017 , ... Sideline Products participated in the World Horse Expo held ... Seay and his production crew. Tom Seay’s program “Best of America by Horseback” ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the clip ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National Heart ... advocates, and individuals join together to increase recognition about the risks of heart ... , “Today we mark a nationwide movement to raise awareness about a disease ...
Breaking Medicine News(10 mins):